| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.085 | 0.2 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |